{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T17:10:16Z","timestamp":1774285816380,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":69,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the Medical Engineering Laboratory of the Chinese PLA General Hospital and the Beijing Key Laboratory for Precision Medicine of Chronic Heart Failure"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-025-04609-w","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T01:35:47Z","timestamp":1768268147000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Potential host-gut microbiota-metabolite associations in cardiorenal syndrome progression: a multi-omics integrative analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Chongyou","family":"Rao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lifan","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aoyi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunlun","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feihu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"17","key":"4609_CR1","doi-asserted-by":"publisher","first-page":"e263","DOI":"10.1016\/j.jacc.2021.12.012","volume":"79","author":"PA Heidenreich","year":"2022","unstructured":"Heidenreich PA, Bozkurt B, Aguilar D, et al. 2022 AHA\/ACC\/HFSA guideline for the management of heart failure. J Am Coll Cardiol. 2022;79(17):e263\u2013421. https:\/\/doi.org\/10.1016\/j.jacc.2021.12.012.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"4609_CR2","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1161\/cir.0000000000001123","volume":"147","author":"CW Tsao","year":"2023","unstructured":"Tsao CW, Aday AW, Almarzooq ZI, et al. Heart disease and stroke statistics-2023 update: a report from the American Heart Association. Circulation. 2023;147(8):e93\u2013621. https:\/\/doi.org\/10.1161\/cir.0000000000001123.","journal-title":"Circulation"},{"issue":"4","key":"4609_CR3","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jacc.2021.05.002","volume":"78","author":"RB Patel","year":"2021","unstructured":"Patel RB, Fonarow GC, Greene SJ, et al. Kidney Function and Outcomes in Patients Hospitalized With Heart Failure. J Am Coll Cardiol. 2021;78(4):330\u201343. https:\/\/doi.org\/10.1016\/j.jacc.2021.05.002.","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"4609_CR4","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1002\/ejhf.2620","volume":"24","author":"RJ Janse","year":"2022","unstructured":"Janse RJ, Fu EL, Dahlstr\u00f6m U, et al. Use of guideline-recommended medical therapy in patients with heart failure and chronic kidney disease: from physician\u2019s prescriptions to patient\u2019s dispensations, medication adherence and persistence. Eur J Heart Fail. 2022;24(11):2185\u201395. https:\/\/doi.org\/10.1002\/ejhf.2620.","journal-title":"Eur J Heart Fail"},{"issue":"2","key":"4609_CR5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nrneph.2012.279","volume":"9","author":"P Hatamizadeh","year":"2013","unstructured":"Hatamizadeh P, Fonarow GC, Budoff MJ, Darabian S, Kovesdy CP, Kalantar-Zadeh K. Cardiorenal syndrome: pathophysiology and potential targets for clinical management. Nat Rev Nephrol. 2013;9(2):99\u2013111. https:\/\/doi.org\/10.1038\/nrneph.2012.279.","journal-title":"Nat Rev Nephrol"},{"issue":"7","key":"4609_CR6","doi-asserted-by":"publisher","first-page":"933","DOI":"10.2215\/cjn.0000000000000064","volume":"18","author":"W McCallum","year":"2023","unstructured":"McCallum W, Sarnak MJ. Cardiorenal syndrome in the hospital. Clin J Am Soc Nephrol. 2023;18(7):933\u201345. https:\/\/doi.org\/10.2215\/cjn.0000000000000064.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9","key":"4609_CR7","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1016\/j.jacc.2020.06.070","volume":"76","author":"JC Jentzer","year":"2020","unstructured":"Jentzer JC, Bihorac A, Brusca SB, et al. Contemporary Management of Severe Acute Kidney Injury and Refractory Cardiorenal Syndrome: JACC Council Perspectives. J Am Coll Cardiol. 2020;76(9):1084\u2013101. https:\/\/doi.org\/10.1016\/j.jacc.2020.06.070.","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"4609_CR8","doi-asserted-by":"publisher","first-page":"e0302203","DOI":"10.1371\/journal.pone.0302203","volume":"19","author":"JJ Shearer","year":"2024","unstructured":"Shearer JJ, Hashemian M, Nelson RG, et al. Demographic trends of cardiorenal and heart failure deaths in the United States, 2011\u20132020. PLoS ONE. 2024;19(5):e0302203. https:\/\/doi.org\/10.1371\/journal.pone.0302203.","journal-title":"PLoS ONE"},{"key":"4609_CR9","doi-asserted-by":"publisher","unstructured":"Lisa A, Carbone F, Liberale L, Montecucco F. The need to identify novel markers for early renal injury in cardiorenal syndrome. Cells. 2024;13(15). https:\/\/doi.org\/10.3390\/cells13151283.","DOI":"10.3390\/cells13151283"},{"issue":"3","key":"4609_CR10","doi-asserted-by":"publisher","first-page":"101509","DOI":"10.1016\/j.cpcardiol.2022.101509","volume":"48","author":"JA Kim","year":"2023","unstructured":"Kim JA, Wu L, Rodriguez M, et al. Recent developments in the evaluation and management of cardiorenal syndrome: a comprehensive review. Curr Probl Cardiol. 2023;48(3):101509. https:\/\/doi.org\/10.1016\/j.cpcardiol.2022.101509.","journal-title":"Curr Probl Cardiol"},{"issue":"6","key":"4609_CR11","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/crd.0000000000000532","volume":"32","author":"S Sohal","year":"2024","unstructured":"Sohal S, Uppal D, Mathai SV, Wats K, Uppal NN. Acute cardiorenal syndrome: an update. Cardiol Rev. 2024;32(6):489\u201398. https:\/\/doi.org\/10.1097\/crd.0000000000000532.","journal-title":"Cardiol Rev"},{"key":"4609_CR12","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.ijcard.2018.11.108","volume":"276","author":"A Palazzuoli","year":"2019","unstructured":"Palazzuoli A, Ruocco G, Pellicori P, et al. The prognostic role of different renal function phenotypes in patients with acute heart failure. Int J Cardiol. 2019;276:198\u2013203. https:\/\/doi.org\/10.1016\/j.ijcard.2018.11.108.","journal-title":"Int J Cardiol"},{"key":"4609_CR13","doi-asserted-by":"publisher","unstructured":"Gallo G, Lanza O, Savoia C. New insight in cardiorenal syndrome: from biomarkers to therapy. Int J Mol Sci. 2023;24(6). https:\/\/doi.org\/10.3390\/ijms24065089.","DOI":"10.3390\/ijms24065089"},{"issue":"2","key":"4609_CR14","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1002\/ehf2.14476","volume":"11","author":"KH Christensen","year":"2024","unstructured":"Christensen KH, Nielsen RR, Schou M, et al. Circulating 3-hydroxy butyrate predicts mortality in patients with chronic heart failure with reduced ejection fraction. ESC Heart Fail. 2024;11(2):837\u201345. https:\/\/doi.org\/10.1002\/ehf2.14476.","journal-title":"ESC Heart Fail"},{"key":"4609_CR15","doi-asserted-by":"publisher","DOI":"10.34067\/kid.0000000797","author":"SM Laville","year":"2025","unstructured":"Laville SM, Jaisson S, Gillery P, et al. Homocitrulline is associated with cardiovascular outcomes in non-dialysis patients with CKD. Kidney360. 2025. https:\/\/doi.org\/10.34067\/kid.0000000797.","journal-title":"Kidney360"},{"issue":"1","key":"4609_CR16","doi-asserted-by":"publisher","first-page":"2505119","DOI":"10.1080\/19490976.2025.2505119","volume":"17","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Wei Y, Han X, et al. Faecalibacterium prausnitzii prevents age-related heart failure by suppressing ferroptosis in cardiomyocytes through butyrate-mediated LCN2 regulation. Gut Microbes. 2025;17(1):2505119. https:\/\/doi.org\/10.1080\/19490976.2025.2505119.","journal-title":"Gut Microbes"},{"key":"4609_CR17","doi-asserted-by":"publisher","unstructured":"Koshida T, Gohda T, Sugimoto T, et al. Gut microbiome and microbiome-derived metabolites in patients with end-stage kidney disease. Int J Mol Sci. 2023;24(14). https:\/\/doi.org\/10.3390\/ijms241411456.","DOI":"10.3390\/ijms241411456"},{"issue":"16","key":"4609_CR18","doi-asserted-by":"publisher","first-page":"e840","DOI":"10.1161\/cir.0000000000000664","volume":"139","author":"J Rangaswami","year":"2019","unstructured":"Rangaswami J, Bhalla V, Blair JEA, et al. Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American Heart Association. Circulation. 2019;139(16):e840\u201378. https:\/\/doi.org\/10.1161\/cir.0000000000000664.","journal-title":"Circulation"},{"issue":"12","key":"4609_CR19","doi-asserted-by":"publisher","first-page":"158813","DOI":"10.1016\/j.bbalip.2020.158813","volume":"1865","author":"GD Lopaschuk","year":"2020","unstructured":"Lopaschuk GD, Karwi QG, Ho KL, Pherwani S, Ketema EB. Ketone metabolism in the failing heart. Biochim Biophys Acta Mol Cell Biol Lipids. 2020;1865(12):158813. https:\/\/doi.org\/10.1016\/j.bbalip.2020.158813.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"issue":"19","key":"4609_CR20","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1016\/j.jacc.2008.07.051","volume":"52","author":"C Ronco","year":"2008","unstructured":"Ronco C, Haapio M, House AA, Anavekar N, Bellomo R. Cardiorenal syndrome. J Am Coll Cardiol. 2008;52(19):1527\u201339. https:\/\/doi.org\/10.1016\/j.jacc.2008.07.051.","journal-title":"J Am Coll Cardiol"},{"key":"4609_CR21","doi-asserted-by":"publisher","first-page":"151642","DOI":"10.1016\/j.ijmm.2024.151642","volume":"318","author":"H Liu","year":"2025","unstructured":"Liu H, Ma X, Yang X, et al. E. coli Nissle 1917 improves gut microbiota composition and serum metabolites to counteract atherosclerosis via the homocitrulline\/Caspase 1\/NLRP3\/GSDMD axis. Int J Med Microbiol. 2025;318:151642. https:\/\/doi.org\/10.1016\/j.ijmm.2024.151642.","journal-title":"Int J Med Microbiol"},{"issue":"4","key":"4609_CR22","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.cardfail.2013.02.001","volume":"19","author":"WH Tang","year":"2013","unstructured":"Tang WH, Shrestha K, Wang Z, et al. Protein carbamylation in chronic systolic heart failure: relationship with renal impairment and adverse long-term outcomes. J Card Fail. 2013;19(4):219\u201324. https:\/\/doi.org\/10.1016\/j.cardfail.2013.02.001.","journal-title":"J Card Fail"},{"issue":"3","key":"4609_CR23","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1038\/ki.2015.166","volume":"88","author":"FH Verbrugge","year":"2015","unstructured":"Verbrugge FH, Tang WH, Hazen SL. Protein carbamylation and cardiovascular disease. Kidney Int. 2015;88(3):474\u20138. https:\/\/doi.org\/10.1038\/ki.2015.166.","journal-title":"Kidney Int"},{"key":"4609_CR24","doi-asserted-by":"publisher","first-page":"813289","DOI":"10.3389\/fmicb.2021.813289","volume":"12","author":"W Sun","year":"2021","unstructured":"Sun W, Du D, Fu T, Han Y, Li P, Ju H. Alterations of the Gut Microbiota in Patients With Severe Chronic Heart Failure. Front Microbiol. 2021;12:813289. https:\/\/doi.org\/10.3389\/fmicb.2021.813289.","journal-title":"Front Microbiol"},{"issue":"1","key":"4609_CR25","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1038\/s41598-017-18756-2","volume":"8","author":"X Cui","year":"2018","unstructured":"Cui X, Ye L, Li J, et al. Metagenomic and metabolomic analyses unveil dysbiosis of gut microbiota in chronic heart failure patients. Sci Rep. 2018;8(1):635. https:\/\/doi.org\/10.1038\/s41598-017-18756-2.","journal-title":"Sci Rep"},{"key":"4609_CR26","doi-asserted-by":"publisher","unstructured":"Ang Li Xuan A, Robert V, Hisatomi A, et al. Faecalibacterium langellae sp. nov. isolated from human faeces. Int J Syst Evol Microbiol. 2025;75(6).\u00a0https:\/\/doi.org\/10.1099\/ijsem.0.006804.","DOI":"10.1099\/ijsem.0.006804"},{"issue":"3","key":"4609_CR27","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1163\/18762891-bja00058","volume":"16","author":"S Zhao","year":"2025","unstructured":"Zhao S, Qu Y, Huang H, et al. Causal relationship between Faecalibacterium abundance and risk of Faecalibacterium-related diseases: a two-sample bi-directional Mendelian randomisation study. Benef Microbes. 2025;16(3):363\u201376. https:\/\/doi.org\/10.1163\/18762891-bja00058.","journal-title":"Benef Microbes"},{"issue":"17","key":"4609_CR28","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1161\/circulationaha.119.043081","volume":"141","author":"DM Kaye","year":"2020","unstructured":"Kaye DM, Shihata WA, Jama HA, et al. Deficiency of prebiotic fiber and insufficient signaling through gut metabolite-sensing receptors leads to cardiovascular disease. Circulation. 2020;141(17):1393\u2013403. https:\/\/doi.org\/10.1161\/circulationaha.119.043081.","journal-title":"Circulation"},{"issue":"12","key":"4609_CR29","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.cardfail.2015.09.017","volume":"21","author":"Y Nagatomo","year":"2015","unstructured":"Nagatomo Y, Tang WH. Intersections between microbiome and heart failure: revisiting the gut hypothesis. J Card Fail. 2015;21(12):973\u201380. https:\/\/doi.org\/10.1016\/j.cardfail.2015.09.017.","journal-title":"J Card Fail"},{"issue":"8","key":"4609_CR30","doi-asserted-by":"publisher","first-page":"2491","DOI":"10.1093\/ndt\/gfq759","volume":"26","author":"S Yamamoto","year":"2011","unstructured":"Yamamoto S, Zuo Y, Ma J, et al. Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice. Nephrol Dial Transplant. 2011;26(8):2491\u20137. https:\/\/doi.org\/10.1093\/ndt\/gfq759.","journal-title":"Nephrol Dial Transplant"},{"issue":"14","key":"4609_CR31","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1093\/eurheartj\/ehp574","volume":"31","author":"S Lekawanvijit","year":"2010","unstructured":"Lekawanvijit S, Adrahtas A, Kelly DJ, Kompa AR, Wang BH, Krum H. Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? Eur Heart J. 2010;31(14):1771\u20139. https:\/\/doi.org\/10.1093\/eurheartj\/ehp574.","journal-title":"Eur Heart J"},{"issue":"10","key":"4609_CR32","doi-asserted-by":"publisher","first-page":"2434","DOI":"10.1681\/asn.2014060543","volume":"26","author":"K Yang","year":"2015","unstructured":"Yang K, Wang C, Nie L, et al. Klotho protects against indoxyl sulphate-induced myocardial hypertrophy. J Am Soc Nephrol. 2015;26(10):2434\u201346. https:\/\/doi.org\/10.1681\/asn.2014060543.","journal-title":"J Am Soc Nephrol"},{"key":"4609_CR33","doi-asserted-by":"publisher","unstructured":"Gryp T, Vanholder R, Vaneechoutte M, Glorieux G. P-cresyl sulfate. Toxins (Basel). 2017;9(2). https:\/\/doi.org\/10.3390\/toxins9020052.","DOI":"10.3390\/toxins9020052"},{"issue":"Suppl 1","key":"4609_CR34","doi-asserted-by":"publisher","first-page":"S49","DOI":"10.2215\/cjn.02720409","volume":"4","author":"JJ Carrero","year":"2009","unstructured":"Carrero JJ, Stenvinkel P. Persistent inflammation as a catalyst for other risk factors in chronic kidney disease: a hypothesis proposal. Clin J Am Soc Nephrol. 2009;4(Suppl 1):S49-55. https:\/\/doi.org\/10.2215\/cjn.02720409.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"14","key":"4609_CR35","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1161\/circulationaha.119.043300","volume":"140","author":"BM Kuehn","year":"2019","unstructured":"Kuehn BM. Gut microbes role in heart failure explored. Circulation. 2019;140(14):1217\u20138. https:\/\/doi.org\/10.1161\/circulationaha.119.043300.","journal-title":"Circulation"},{"key":"4609_CR36","doi-asserted-by":"publisher","unstructured":"Freise C, Metzkow S, Zappe A, et al. The Uremic Toxins Inorganic Phosphate, Indoxylsulphate, p-Cresylsulphate, and TMAO Induce the Generation of Sulphated Glycosaminoglycans in Aortic Tissue and Vascular Cells via pAKT Signaling: A Missing Link in the \u201cGut-Matrix Axis.\u201d Toxins (Basel). 2025;17(5). https:\/\/doi.org\/10.3390\/toxins17050217.","DOI":"10.3390\/toxins17050217"},{"key":"4609_CR37","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.yjmcc.2020.12.001","volume":"152","author":"P Mamic","year":"2021","unstructured":"Mamic P, Chaikijurajai T, Tang WHW. Gut microbiome - a potential mediator of pathogenesis in heart failure and its comorbidities: state-of-the-art review. J Mol Cell Cardiol. 2021;152:105\u201317. https:\/\/doi.org\/10.1016\/j.yjmcc.2020.12.001.","journal-title":"J Mol Cell Cardiol"},{"issue":"2","key":"4609_CR38","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.cardfail.2021.08.008","volume":"28","author":"M Vaduganathan","year":"2022","unstructured":"Vaduganathan M, Fonarow GC, Greene SJ, et al. Treatment persistence of renin-angiotensin-aldosterone-system inhibitors over time in heart failure with reduced ejection fraction. J Card Fail. 2022;28(2):191\u2013201. https:\/\/doi.org\/10.1016\/j.cardfail.2021.08.008.","journal-title":"J Card Fail"},{"issue":"10","key":"4609_CR39","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1161\/circulationaha.116.024545","volume":"135","author":"FZ Marques","year":"2017","unstructured":"Marques FZ, Nelson E, Chu PY, et al. High-fiber diet and acetate supplementation change the gut microbiota and prevent the development of hypertension and heart failure in hypertensive mice. Circulation. 2017;135(10):964\u201377. https:\/\/doi.org\/10.1161\/circulationaha.116.024545.","journal-title":"Circulation"},{"issue":"10","key":"4609_CR40","doi-asserted-by":"publisher","first-page":"e016223","DOI":"10.1161\/jaha.119.016223","volume":"9","author":"CL Organ","year":"2020","unstructured":"Organ CL, Li Z, Sharp TE, et al. Nonlethal inhibition of gut microbial trimethylamine N-oxide production improves cardiac function and remodeling in a murine model of heart failure. J Am Heart Assoc. 2020;9(10):e016223. https:\/\/doi.org\/10.1161\/jaha.119.016223.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"4609_CR41","doi-asserted-by":"publisher","first-page":"e038461","DOI":"10.1161\/jaha.124.038461","volume":"14","author":"H Guldbrandsen","year":"2025","unstructured":"Guldbrandsen H, Gopalasingam N, Christensen KH, et al. Cardiovascular and metabolic effects of modulating circulating ketone bodies with 1,3-butanediol in patients with heart failure with reduced ejection fraction. J Am Heart Assoc. 2025;14(1):e038461. https:\/\/doi.org\/10.1161\/jaha.124.038461.","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"4609_CR42","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1093\/cid\/ciy149","volume":"66","author":"LC McDonald","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S, et al. Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis. 2018;66(7):987\u201394. https:\/\/doi.org\/10.1093\/cid\/ciy149.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-025-04609-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04609-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-025-04609-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:34:19Z","timestamp":1774283659000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-025-04609-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4609"],"URL":"https:\/\/doi.org\/10.1186\/s12866-025-04609-w","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"5 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study was conducted following the Declaration of Helsinki and approved by the Ethics Committees of the Affiliated Hospital of Chengde Medical University (CYFYLL2023196) and the First Affiliated Hospital of Henan University of Science and Technology\u00a0(2023\u201303-K0026). It was also registered in the\n                      Chinese Clinical Trial Registry\n                      (Clinical trial number: ChiCTR2300071422).During the recruitment phase, the researchers provided comprehensive details of the research protocol to all potential participants. All participants provided signed informed consent before undergoing blood and fecal sample collection, as well as the collection of personal information. The participation process strictly adhered to the principle of voluntary participation: participants were allowed to withdraw from the study at any time without providing a reason, and the anonymized data already collected would be retained or deleted according to their preferences.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"263"}}